Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ACTIVE NOT RECRUITING NA

Ostomy Rural Telehealth Training Cancer Survivors

NCT03913715 · View on ClinicalTrials.gov ↗

Study Summary

Over one million individuals in the U.S. have ostomies. The American Cancer Society estimates 43,030 rectal cancer cases and 81,190 bladder cancer cases will be diagnosed in 2018.Of these, at least 30,000 will receive ostomies, and an additional unknown number due to gynecologic, other gastrointestinal, or other gastro-urinary tumors. The health-related quality of life impact is tremendous and greater than with many other cancer treatments. An ostomy is often a prolonged or lifelong disabling problem for cancer survivors. The adaptation period is quite variable. In our R01 study, 18% of participants took at least one year to be comfortable, or never felt comfortable, in managing their ostomy care. Importantly, many patients cannot attend in-person self-management programs or patient groups for a myriad of reasons, including distance to travel, lack of access to transportation, monetary outlays, competing demands (such as work), or comorbidities making travel difficult. In addition, a national shortage of OCNs means patients with an ostomy, whether newly placed or a long-term issue, receive little help. It is imperative to study interventions for rural survivors aimed to limit family financial burdens, improve ostomy outcomes, and improve survivors' well-being.

Interventions

  • OTHER Ostomy Self-Management Training

Study Locations (10)

Pennsylvania

  • Geisinger — Danville
  • Lancaster General Hospital — Lancaster
  • Penn Medicine — Philadelphia

California

  • City Of Hope — Duarte
  • Loma Linda University Health — Loma Linda

Arkansas

  • University of Arkansas For Medical Sciences — Little Rock

New Mexico

  • University of New Mexico — Albuquerque

North Carolina

  • University of North Carolina — Chapel Hill

North Dakota

  • Sanford Research Center — Fargo

South Carolina

  • University of South Carolina Greenville (Prisma Health) — Greenville

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2019-08-01
Est. Completion 2026-10-31
Phase NA

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03913715

The ClinicalTrials.gov registry entry for NCT03913715 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 332 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention — of which Ostomy Self-Management Training is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT03913715 reports 10 study locations spanning 7 distinct geographic areas — top geographies include Pennsylvania, California, Arkansas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT03913715 about?

NCT03913715 is a clinical study titled "Ostomy Rural Telehealth Training Cancer Survivors". Over one million individuals in the U.S. have ostomies. The American Cancer Society estimates 43,030 rectal cancer cases and 81,190 bladder cancer cases will be diagnosed in 2018.Of these, at least 30,000 will receive ostomies, and an additional unknown number due to gynecologic, other gastrointesti...

What is the current status of trial NCT03913715?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2019-08-01. Estimated completion is 2026-10-31.

What conditions does trial NCT03913715 study?

This clinical trial studies the following conditions: Quality of Life, Ostomy, Telehealth. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT03913715?

The interventions under investigation include: Ostomy Self-Management Training (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT03913715?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 332 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT03913715 being conducted?

This trial has 10 study locations across Arkansas, California, New Mexico, North Carolina, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial